Specific c-Jun target genes in malignant melanoma
暂无分享,去创建一个
P. Schummer | A. Bosserhoff | S. Kuphal | Anja K Bosserhoff | L. Vardimon | Patrick Schummer | Silke Kuphal | Lily Vardimon | Melanie Kappelmann | M. Kappelmann | Melanie Kappelmann
[1] H. Simon,et al. Autophagy suppresses melanoma tumorigenesis by inducing senescence , 2014, Autophagy.
[2] Charles Elkan,et al. Fitting a Mixture Model By Expectation Maximization To Discover Motifs In Biopolymer , 1994, ISMB.
[3] T. Kerppola,et al. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity , 2001, Oncogene.
[4] J. McCubrey,et al. Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma , 2012, Oncotarget.
[5] M. Karin,et al. AP-1 in cell proliferation and survival , 2001, Oncogene.
[6] E. Wagner,et al. Control of cell cycle progression by c-Jun is p53 dependent. , 1999, Genes & development.
[7] Richard A Young,et al. Chromatin immunoprecipitation and microarray-based analysis of protein location , 2006, Nature Protocols.
[8] J. Barrett,et al. Pathway-Based Analysis of a Melanoma Genome-Wide Association Study: Analysis of Genes Related to Tumour-Immunosuppression , 2011, PloS one.
[9] M. Bar‐eli,et al. Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry. , 2008, The American journal of pathology.
[10] Juan Wang,et al. Aberrant Expression of Beclin-1 and LC3 Correlates with Poor Prognosis of Human Hypopharyngeal Squamous Cell Carcinoma , 2013, PloS one.
[11] O. Wolkenhauer,et al. Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma , 2013, Oncogene.
[12] G. von Heijne,et al. Tissue-based map of the human proteome , 2015, Science.
[13] Davide Heller,et al. STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..
[14] E. Wagner,et al. JunB suppresses cell proliferation by transcriptional activation of p16INK4a expression , 2000, The EMBO journal.
[15] K. Milde-Langosch,et al. Expression pattern of the AP‐1 family in breast cancer: Association of fosB expression with a well‐differentiated, receptor‐positive tumor phenotype , 1999, International journal of cancer.
[16] Dong-hao Wu,et al. Autophagic LC3B overexpression correlates with malignant progression and predicts a poor prognosis in hepatocellular carcinoma , 2014, Tumor Biology.
[17] W. Nishio,et al. The role of Necl-5 in the invasive activity of lung adenocarcinoma. , 2013, Experimental and molecular pathology.
[18] Paola Baldassari,et al. NFATc2 is a potential therapeutic target in human melanoma. , 2012, The Journal of investigative dermatology.
[19] F. Meyskens,et al. During human melanoma progression AP-1 binding pairs are altered with loss of c-Jun in vitro. , 2004, Pigment cell research.
[20] David Bryant,et al. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists , 2007, Nucleic Acids Res..
[21] Tao Lu,et al. Role of ChIP-seq in the discovery of transcription factor binding sites, differential gene regulation mechanism, epigenetic marks and beyond , 2014, Cell cycle.
[22] E. Bossy‐Wetzel,et al. Cell cycle‐dependent variations in c‐Jun and JunB phosphorylation: a role in the control of cyclin D1 expression , 2000, The EMBO journal.
[23] M. Karin,et al. Transcriptional interference between c-Jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction , 1990, Cell.
[24] E. Shaulian. AP-1--The Jun proteins: Oncogenes or tumor suppressors in disguise? , 2010, Cellular signalling.
[25] A. Bosserhoff,et al. Death inducer-obliterator 1 (Dido1) is a BMP target gene and promotes BMP-induced melanoma progression , 2013, Oncogene.
[26] Brad T. Sherman,et al. The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists , 2007, Genome Biology.
[27] A. Bosserhoff,et al. AP-1/c-Jun transcription factors: regulation and function in malignant melanoma. , 2014, European journal of cell biology.
[28] A. Bosserhoff,et al. MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression , 2013, Oncogene.
[29] C. Weiss,et al. Deregulated Repression of c-Jun Provides a Potential Link to its Role in Tumorigenesis , 2004, Cell cycle.
[30] D. Louis,et al. CD155/PVR plays a key role in cell motility during tumor cell invasion and migration , 2004, BMC Cancer.
[31] A. Bosserhoff,et al. Functional role of MIA in melanocytes and early development of melanoma , 2004, Oncogene.
[32] S. Grässel,et al. The transcription factor AP-2ɛ regulates CXCL1 during cartilage development and in osteoarthritis. , 2011, Osteoarthritis and cartilage.
[33] Michael D. Taylor,et al. Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma , 2014, Molecular Cancer.
[34] E. Wagner,et al. AP-1: a double-edged sword in tumorigenesis , 2003, Nature Reviews Cancer.
[35] A. Bosserhoff,et al. Post‐transcriptional regulation controlled by E‐cadherin is important for c‐Jun activity in melanoma , 2011, Pigment cell & melanoma research.
[36] S. Choi,et al. RGS16 and FosB underexpressed in pancreatic cancer with lymph node metastasis promote tumor progression , 2010, Tumor Biology.
[37] A. Bosserhoff,et al. ETS‐1/RhoC signaling regulates the transcription factor c‐Jun in melanoma , 2012, International journal of cancer.
[38] V. Sondak,et al. Inhibition of Wee1, AKT, and CDK4 Underlies the Efficacy of the HSP90 Inhibitor XL888 in an In Vivo Model of NRAS-Mutant Melanoma , 2013, Molecular Cancer Therapeutics.
[39] P. Vogt,et al. Jun, the oncoprotein , 2001, Oncogene.
[40] A. Ghaderi,et al. Tumour suppressive effects of WEE1 gene silencing in breast cancer cells. , 2013, Asian Pacific journal of cancer prevention : APJCP.
[41] D. McConkey,et al. Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin. , 2012, Cancer research.
[42] Z. Krawczyk,et al. Melanoma-associated genes, MXI1, FN1, and NME1, are hypoxia responsive in murine and human melanoma cells , 2011, Melanoma research.
[43] V. A. Flørenes,et al. Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions. , 2014, Gynecologic oncology.
[44] E. Wagner,et al. AP-1 in mouse development and tumorigenesis , 2001, Oncogene.